Inflammatory thyroid disorders

Otolaryngologic Clinics of North America

Volumn 36, Issue 1, 2003, Pages 55-71

  Sniezek, Joseph C ^a   Francis, Thomas B ^a,b  

^a TRIPLER ARMY MEDICAL CENTER   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOCORTICOID; INTERFERON; IODINE 131; LEVOTHYROXINE; NONSTEROID ANTIINFLAMMATORY AGENT;

BACTERIAL INFECTION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; GRAVES DISEASE; HASHIMOTO DISEASE; HEALTH CARE; HUMAN; IDIOPATHIC DISEASE; INFLAMMATION; INFLAMMATORY THYROID DISEASE; OTORHINOLARYNGOLOGY; REVIEW; THYROID DISEASE; THYROIDITIS; VIRUS INFECTION;

AMIODARONE; HUMANS; THYROIDITIS; TREATMENT OUTCOME;

EID: 0037303302     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6665(02)00133-0     Document Type: Review

References (118)

1. Slatosky J, Shipton B, Wahba H. Thyroiditis: differential diagnosis and management. Am Fam Phys 2000;61(4):1047-52.
2. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrin Metab Clin North Amer 2001;30(2):315-37.
3. Fatourechi V, McConahey WM, Woolner LB. Hyperthyroidism associated with histologic Hashimoto's thyroiditis. Mayo Clin Proc 1971;41:682.
4. Hedley AJ, Young RE, Jones SJ, et al. Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow-up of 434 patients. Clin Endocrinol 1989;31:209.
5. Kasagi K, Hidaka A, Endo K, et al. Fluctuating thyroid function depending on the balance between stimulating and blocking type of TSH receptor antibodies: a case report. Thyroid 1993;3:315.
6. Tamai H, Hirota Y, Kasagi K, et al. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment. J Clin Endocrinol Metab 1987;64:718.
7. Kraiem Z, Baron E, Kahana L, et al. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo- to hyperthyroidism and back to hypothyroidism. Clin Endocrinol 1992;36:214.
8. Ducornet B, Moisson-Meer A, Duprey J. Hypothyroidism and blocking thyrotropin receptor antibodies. Ann Med Interne (Paris) 1995;146:558.
9. Caixas A, Albareda M, Garcia-Patterson A, et al. Postpartum thyroiditis in women with hypothyroidism antedating pregnancy? J Clin Endocrinol Metab 1999;84:4000-5.
10. Becker KL, editor. Principles and practice of endocrinology and metabolism. 2nd edition Philadelphia: Lipincott-Raven; 1995.
11. Monotani N, Noh J, Ishikawa N, et al. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period. J Clin Endocrinol Metab 1994;79:285.
12. Fatourechi V. Demystifying autoimmune thyroid disease. Which disorders require treatment? Postgrad Med 2000;107(1):127-34.
13. Ho SC. Thyroxtoxicosis due to the simultaneous occurrence of silent thyroiditis and Graves' disease. Thyroid 1999;9(11):1127-32.
14. Hamburger JI. The various presentations of thyroiditis: diagnostic considerations. Ann Intern Med 1986;104:219-24.
15. Sakiyama R. Thyroiditis: a clinical review. Am Fam Physician 1993;48:615-21.
16. Farwell AP, Braverman LE. Inflammatory thyroid disorders. Otolaryngol Clin North Am 1996;29:541-56.
17. Schubert MF, Kountz DS. Thyroiditis: a disease with many faces. Postgrad Med 1995; 98:101-12.
18. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996;335: 99-107.
19. Belfiore A, La Rosa GL. Fine-needle aspiration biopsy of the thyroid. Endocrinolol Metab Clin North Am 2001;30(2):361-400.
20. Matsubayashi S. The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 1995;80(12):3421-4.
21. Kossev P, Livolsi V. Lymphoid lesions of the thyroid: review in light of the revised European-American lymphoma classification and upcoming World Health Organization classification. Thyroid 1999;9(12):1273-80.
22. Gharib H. Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 1997;26(4):777-800.
23. Ross DS. Syndromes of thyrotoxicosis with low radioactive iodine uptake. Endocrinol Metabol Clin North Am 1998;27:169-86.
24. Nikolai TF, Brosseau J, Kettrick MA, et al. Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis). Arch Intern Med 1980;140:478.
25. Woof P. Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? Endocr Rev 1980;1:411.
26. Gerstein HC. How common is postpartum thyroiditis? A methodologic overview of the literature. Arch Intern Med 1990;150:1397.
27. Alvarez-Marfany M, Roman S, Drexler A, et al. Long-term prospective study of postpartum thyroid dysfunction in women with insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1994;79:10.
28. Stagnaro-Green A. Recognizing, understanding, and treating postpartum thyroiditis. Endocrin Metab Clin North Amer 2000;29(2):417-30.
29. Singer PA. Thyroiditis: acute, subacute, and chronic. Med Clin North Am 1991;75:61-77.
30. Solomon BL, Fein HG, Smallridge RC. Usefulness of antimicrosomal antibody titres in the diagnosis and treatment of postpartum thyroiditis. J Fam Pract 1993;36:177.
31. Larimore WL, Petrie KA. Drug use during pregnancy and lactation. Prim Care 2000; 27(1):35-53.
32. Braverman LE, Utiger RD, editors. Werner and Ingbar's the thyroid: a fundamental and clinical text. 7th edition Philadelphia: Lipincott-Raven; 1997.
33. Check JH, Avellino J. Painless thyroiditis and transient thyrotoxicosis after Graves' disease. JAMA 1980;244:1361.
34. Durelli L, Ferrero B, Oggero A, et al. Liver and thyroid function and autoimmunity during interferon-Blb treatment for MS. Neurology 2001;57:1363-70.
35. Dusheiko G. Side effects of alpha interferon in chronic hepatitic C. Hepatology 1997;26(3):112S-21.
36. Watanabe U, Hashimnoto E, Hisamitsu T, et al. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am J Gastroenterol 1994;89:399-403.
37. Durelli L. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. J Clin Endocrinol Metab 2001;86(8):3525-32.
38. Monzani F. Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful? Neurology 2000;55(4):549-52.
39. Ronnblom LE, Alm GV, Oberg KE. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Intern Med 1991;115:178.
40. Dabon-Almirante CLM, Surks MI. Clinical and laboratory diagnosis of thyrotoxicosis. Endocrinol Metab Clin North Am 1998;27(1):25-35.
41. Schwartz KM. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 2002;87(2):438-46.
42. Bahn RS. Understanding the immunology of Graves' ophthalmopathy: is it an autoimmune disease? Endocrinol Metab Clin North Am 2000;29(2):287.
43. Gough S. The genetics of Graves' disease. Endocrinol Metab Clin North Am 2000; 29(2):255-66.
44. Vanderpump PJ, Unbrgiedge WMG. The epidemiology of autoimmune thyroid disease. In: Volpe P, editor. Autoimmune endocrinopathies. Totowa (NJ): Humana Press; 1999. p. 141-3.
45. Graves PN, Davies TF. New insights into the thyroid-stimulating hormone receptor: the major antigen of Graves' disease. Endocrinol Metab Clin North Am 2000;29(2):267-86.
46. McIver B, Morris JC. The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am 1998;27(1):73-89.
47. Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 2000;29(2):339-55.
48. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am 2000;30(2):315.
49. Gardas A, Blottner A, Domek H. Comparison of autoantibody level in thyroid autoimmune diseases estimated by different methods. Exp Clin Endocrinol 1988;92:77.
50. Torrens JL, Burch HB. Serum thyroglobulin measurement: utility in clinical practice. Endocrinol Metab Clin North Am 2001;30(2):429.
51. Mazzaferri EL. Evaluation and management of common thyroid disorders in women. Am J Obstet Gynecol 1997;176(3):507-14.
52. Hershman JM. Role of human chorionic gonadotropin as a thyroid stimulator. J Clin Endocrinol Metab 1992;74:258-9.
53. Meier DA, Kaplan MM. Radioiodine uptake and thyroid scintiscanning. Endocrinol Metab Clin North Am 2000;30(2):291-313.
54. Kaplan MM, Medier DA, Dworkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrinol Metab Clin North Am 1998;27(1):205-23.
55. Cantalamessa L. Thyroid nodules in Graves' disease and the risk of thyroid carcinoma. Arch Intern Med 1999;159(15):1705.
56. Hegedus L. Thyroid ultrasound. Endocrinol Metab Clin North Am 2000;30(2):339.
57. Pellegriti G, Belfiore A, Guiffrida D, et al. Outcome of differentiated thyroid cancer in Graves' patients. J Clin Endocrinol Metabl 1998;83:2805-9.
58. Mazzaferri EL. Thyroid cancer and Graves' disease. J Clin Endocrinol Metab 1990;70: 826-9.
59. Ozaki O, Ito K, Kobayashi K, et al. Thyroid carcinoma in Graves' disease. World J Surg 1990;14:437-44.
60. Behar R, Arganini M, Wu TC, et al. Graves' disease and thyroid cancer. Surgery 1986; 100:1121-7.
61. Jennings A. Evaluation of substernal goiters using computed tomography and MR imaging. Endocrinol Metab Clin North Am 2000;30(2):401.
62. Henzen C. Iodine-induced hyperthyroidism (Iodine-induced Basedow's disease): a current disease picture. Schweiz Med Wochenschr 1999;129(17):658.
63. Burman KD. Iodine effects on the thyroid gland: biochemical and clinical aspects. Rev Endocr Metab Disord 2000;1(1-2):19-25.
64. Cooper DS. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease. Endocrinol Metab Clin North Am 1998;27(1):225-47.
65. Alsanea O, Clark OH. Treatment of Grave's disease: the advantages of surgery. Endocrinol Metab Clin North Am 2000;30(2):321.
66. Zimmerman D, Lteif AN. Thyrotoxicosis in children. Endocrinol Metab Clin North Am 1998:27(1):109-26.
67. Mestman JH. Hyperthyroidism in pregnancy. Endocrinol Metab Clin North Am 1998; 27(1):127-49.
68. Fatourechi V. Medical treatment of Graves' ophthalmopathy. Ophthalmol Clin North Am 2000;13(4):683-91.
69. Coyle PJ, Mitchell JE. Thyroidectomy: is Lugol's iodine necessary? Ann R Coll Surg 1982;54:334.
70. Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med 1995;122:689-700.
71. Daniels GH. Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 2001; 86(1):3-8.
72. Harjai KJ. Effects of amiodarone on thyroid function. Ann Intern Med 1997;126:63-73.
73. Sinha MK. Amiodarone induced hyperthyroidism. Postgrad Med J 2001;77(907):358.
74. Goichot B. Amiodarone-induced hyperthyroidism. Arch Intern Med 2001;161(2):295.
75. Martino E, Aghini-Lombardi F, Mariotti S, et al. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest 1986;9:201-7.
76. Reichert LJ, de Rooy HA. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. BMJ 1989;298:1547-8.
77. Benbassat CA. Amiodarone-induced thyrotoxicosis type 2: a case report and review of the literature. Am J Med Sci 2000;320(4):288-91.
78. Roti E, Minelli R, Gardini E, et al. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone: a possible consequence of a destructive process in the thyroid. Arch Intern Med 1993:13:886-92.
79. Benbassat CA, Mechlis-Frish S, Cohen M, et al. Amiodarone-induced thyrotoxicosis type 2: a case report and review of the literature. Am J Med Sci 2000;320(4):288-91.
80. Eaton SE. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf) 2002;56(1):33-8.
81. Bogazzi F, Bartalena L, Brogioni S, et al. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone induced thyrotoxicosis. Thyroid 1997;7: 541-5.
82. Osman F, Franklyn JA, Sheppard MC. et al. Successful treatment of amiodarone-induced thyrotoxicosis. Circulation 2002:105:1275-7.
83. Bartalena L, Brogioni S, Grasso L, et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996;81:2930-3.
84. Meuirisse M, Hamoir E, D'Silva M, et al. Amiodarone-induced thyrotoxicosis: is there a place for surgery'? World J Surg 1993;17:622-7.
85. Claxton S. Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy. Aust N Z J Surg 2000;70(3):174-8.
86. Farwell AP, Abend SL, Huang SKS, et al. Thyroidectomy for amiodarone-induced thyrotoxicosis. JAMA 1990;263:1526-8.
87. Meurisse M, Iatrogenic thyrotoxicosis: causal circumstances, pathophysiology, and principles of treatment-review of the literature. World J Surg 2000;24(11):1377-85.
88. Martin F. Role of surgery in treatment of hyperthyroidism. Ann Otolaryngol Chir Cervicofac 1999;116(4):184-97.
89. Dariel MP. Value of total thyroidectomy in amiodarone-induced hyperthyroidism. Ann Otolaryngol Chir Cervicofac 2001;118(4):249-53.
90. Hung W. Mumps, thyroiditis and hypothyroidism. J Pediatr 1969;74:611.
91. Volpe R, Row VV, Ezrin C. Circulating viral and thyroid antibodies in subacute thyroiditis. J Clin Endocrinol Metab 1967;27:1275.
92. Greene JN. Subacute thyroiditis. Am J Med 1971;51:97.
93. Ohsako N, Tamai H, Sudo T, et al. Clinical characteristics of subacute thyroiditis classified according to human leukocyte antigen typing. J Clin Endocrinol Metab 1995; 80:3653.
94. Iitaka M, Momotani N, Ishii J. Incidence of subacute thyroiditis recurrences after a prolonged latency: 24-year survey. J Clin Endocrinol Metab 1996;81:466.
95. Berger SA, Zonszein J, Villamena P, et al. Infectious disease of the thyroid gland. Rev Infect Dis 1983;5:108-22.
96. Hazard JB. Thyroiditis. A review. Am J Clin Pathol 1955;25:289.
97. Ueda J, Kobayashi Y, Hara K, et al. Routes of infection of acute suppurative thyroiditis diagnosed by barium examination. Acta Radiol Diag 1986;27(2):209.
98. Miyauchi A, Matsuzuka F, Takai S, et al. Piriform sinus fistula. Arch Surg 1981;116:66-9.
99. Mandell DL. Head and neck anomalies related to the branchial apparatus. Otolaryngol Clin North Am 2000;33(6):1309-32.
100. Cases JA. Recurrent acute suppurative thyroiditis in an adult due to a fourth branchial pouch fistula. J Clin Endocrinol Metab 2000;85(3):953-6.
101. Takai S, Miyauchi A, Matsuzuka F, et al. Internal fistula as a route of infection in acute suppurative thyroiditis. Lancet 1979;1:751-2.
102. Chi H. Acute suppurative thyroiditis in children. Pediatr Infect Dis J 2002;21(5):384.
103. Doi O, Hutson JM, Myers NA, et al. Branchial remnants: a review of 58 cases. J Pediatr Surg 1988;23:789-92.
104. Kubota M, Suita S, Kamimura T, et al. Surgical strategy for the treatment of pyriform sinus fistula. J Pediatr Surg 1997;32:34-7.
105. Nonomura N, Ikarashi F, Fujisaki T, et al. Surgical approach to pyriform sinus fistula. Am J Otolaryngol 1993;14:111-5.
106. Bernard PJ, Som PM, Urken ML, et al. The CT findings of acute thyroiditis and acute suppurative thyroiditis. Otolaryngol Head Neck Surg 1988;99:489-93.
107. Weber AL. CT and MR imaging evaluation of neck infections with clinical correlations. Radiol Clin North Am 2000;38(5):941-68.
108. Ahuja AT, Griffiths JF, Roebuck DJ, et al. The role of ultrasound and oesophagography in the management of acute suppurative thyroiditis in children associated with congenital pyriform fossa sinus. Clin Radiol 1998;53:209-11.
109. Stone ME. A new role for computed tomography in the diagnosis and treatment of pyriform sinus fistula. Am J Otolaryngol 2000;21(5):323-5.
110. Scowden EB, Schaffner W, Stone WJ. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 1978;57:527-44.
111. Leelachaikul P, Chuahirun S. Cysticercosis of the thyroid gland in severe cerebral cysticercosis: report of a case. J Med Assoc Thai 1977;60:405.
112. Reichert CM, O'Leary TJ, Levens DL, et al. Autopsy pathology in the acquired immunodeficiency syndrome. Am J Pathol 1983;112:357-82.
113. Orkar KS. Pyogenic thyroiditis and HIV infection. West Afr J Med 2001;20(2):173-5.
114. Papi G. Riedel's thyroiditis: clinical, pathological and imaging features. Int J Clin Pract 2002;56(1):65-7.
115. Takahashi N. MR findings with dynamic evaluation in Riedel's thyroiditis. Clin Imaging 2002;26(2):89-91.
116. Malotte MS, Chonkich GD, Zuppan CW. Riedel's thyroiditis. Arch Otolaryngol Head Neck Surg 1991;117:214-7.
117. De Toma G. Therapeutic approach in Riedel thyroiditis. Ann Ital Chir 2000;71(3):349-53.
118. De M. Tamoxifen therapy in steroid resistant Reidel's thyroiditis. Scott Med J 2001; 46(2):56-7.